Resident Mike Morris expressed that the project will burden the community, citing existing congestion on local roads. He stated, 'This is the wrong neighborhood for such a massive project.'
Keytruda, first approved in 2014, belongs to a class of immunotherapy drugs that enable the immune system to attack cancer cells, extending survival for millions and transforming fatal diagnoses into manageable conditions.
Maria Kilcommins was living life as normal with no symptoms whatsoever of cancer when she experienced a seizure on December 19, 2011. This unexpected event led to her cancer diagnosis, which drastically changed her life.
The study published in the Lancet analyzed data from 381 patients with platinum-resistant ovarian cancer, revealing a 35% reduction in the risk of death among those treated with relacorilant compared to usual care.
The INLIGHT interim readout reported a 14.3% placebo-adjusted reduction in visceral fat six months after a single dose, alongside preservation of lean muscle mass - a differentiated profile compared to GLP-1 therapies that often reduce muscle alongside fat.
Nancy Doherty claimed that her employer reduced her hours because it no longer wanted her as the 'face' of the business after her cancer treatment.
Dr. Bishop and Varmus showed that oncogenes - genes that cause cancer - are not foreign genes introduced into the body by viruses, as was widely believed at the time. Instead, normal versions of oncogenes are present in healthy cells, where they help regulate normal growth.
The analysis by Food & Water Watch found that 60% of counties with high glyphosate use had non-Hodgkin lymphoma rates above the national average, indicating a strong correlation between glyphosate application and cancer incidence.
Using CRISPR-Cas9 and adeno-associated virus (AAV)-mediated homology-directed repair, we targeted CAR integration into the endogenous human TCR alpha locus (TRAC). TRAC-CAR T cells display dynamic CAR expression that delays exhaustion and improves tumour control in xenograft and immunocompetent models. This work has been critical for the development of allogeneic CAR T cell therapy, as it disrupts the TCR after transgene insertion—a necessary step to limit graft-versus-host disease.
